Heart Rate Variability (HRV): Which Tests to Order Alongside

What HRV Actually Measures and Why a Single Number Is Not Enough

Heart rate variability quantifies the time differences between consecutive heartbeats, expressed in milliseconds. A healthy autonomic nervous system constantly adjusts these intervals in response to breathing, posture, stress, and metabolic demand. The most commonly reported metric, RMSSD (root mean square of successive differences), captures short-term parasympathetic activity, while SDNN reflects total autonomic variability over longer recording windows [1].

HRV is a downstream signal. It tells you the autonomic nervous system is struggling, but not the upstream cause. A 38-year-old with an RMSSD of 15 ms could be dealing with undiagnosed subclinical hypothyroidism, early insulin resistance, chronic systemic inflammation, or simply poor sleep. Without companion bloodwork, the clinical value of HRV monitoring stays limited to pattern tracking. The European Society of Cardiology's Task Force on HRV measurement standards emphasized that HRV assessment "should not be interpreted in isolation from clinical context and supporting investigations" [2]. That context comes from lab work.

The Core Paired Panel: Seven Tests Every HRV Assessment Should Include

Start with seven tests. These cover the metabolic, inflammatory, and endocrine axes most likely to suppress or distort autonomic tone.

1. Hemoglobin A1c (HbA1c). Glycemic control directly affects cardiac autonomic neuropathy. The DCCT/EDIC follow-up (N=1,184) demonstrated that each 1% increase in HbA1c was associated with a 2.7 ms decrease in RMSSD over 14 years of follow-up [3]. An A1c above 5.7% warrants closer scrutiny of HRV trends.

2. Fasting insulin. Hyperinsulinemia precedes frank diabetes by years and independently predicts reduced HRV. The Framingham Heart Study offspring cohort (N=1,919) found that fasting insulin in the top quartile correlated with significantly lower total HRV power, even after adjusting for BMI and blood pressure [4].

3. Fasting glucose. Paired with A1c and insulin, fasting glucose completes the glycemic triad. It also helps calculate HOMA-IR, which quantifies insulin resistance with a simple formula.

4. High-sensitivity C-reactive protein (hsCRP). Chronic low-grade inflammation suppresses vagal tone. A meta-analysis of 26 studies (combined N=8,463) found an inverse association between CRP levels and HRV parameters, with the strongest effect on SDNN and RMSSD [5]. An hsCRP above 2.0 mg/L alongside low HRV suggests inflammation-mediated autonomic dysfunction.

5. TSH and free T4. Both overt and subclinical hypothyroidism reduce HRV. A study published in the European Journal of Endocrinology (N=42 subclinical hypothyroid patients vs. 42 controls) showed that SDNN was 23% lower in the subclinical group, and that levothyroxine treatment partially restored autonomic balance within 6 months [6].

6. Morning cortisol. The hypothalamic-pituitary-adrenal axis modulates sympathovagal balance directly. Chronically elevated cortisol from Cushing syndrome, chronic stress, or exogenous glucocorticoids shifts the autonomic system toward sympathetic dominance, suppressing HRV. A morning serum cortisol between 6 and 18 mcg/dL is the typical reference range; values at either extreme warrant further workup with a 24-hour urinary free cortisol or late-night salivary cortisol [7].

7. Standard lipid panel. Dyslipidemia clusters with metabolic syndrome, and multiple cross-sectional studies link elevated triglycerides and low HDL-C with reduced HRV. The lipid panel does not explain the HRV finding on its own, but it completes the cardiometabolic risk profile that gives context to an abnormal reading.

Extended Panel: When to Add Hormonal and Micronutrient Testing

The core seven tests will identify the most common drivers. Certain clinical scenarios call for a deeper look.

DHEA-S and total/free testosterone. In men over 40 with fatigue, reduced exercise tolerance, and low HRV, checking the androgen axis makes sense. The European Male Ageing Study (EMAS, N=3,369) found that men with total testosterone below 300 ng/dL had lower HRV indices, with partial recovery observed after testosterone replacement in a subset analysis [8]. For women, DHEA-S can signal adrenal reserve status, which is relevant when cortisol alone does not explain the clinical picture.

RBC magnesium. Serum magnesium misses intracellular depletion. RBC magnesium provides a better approximation. Magnesium deficiency is common (estimated prevalence 10-30% in the general population per NHANES data) and independently associated with lower HRV. A randomized controlled trial of 500 mg/day magnesium supplementation over 12 weeks in adults with low baseline levels showed a 12% improvement in RMSSD compared to placebo [9].

Ferritin. Iron deficiency without anemia affects autonomic function. A study in Clinical Autonomic Research found that women with ferritin below 20 ng/mL had significantly reduced HRV that improved after 8 weeks of iron supplementation [10].

Vitamin D (25-hydroxyvitamin D). The data here are mixed. Several observational studies report associations between low vitamin D and reduced HRV, but interventional data are weaker. The Endocrine Society's 2024 guideline update recommends against routine screening in asymptomatic individuals [11]. Order it when clinical suspicion is high (limited sun exposure, dark skin, malabsorption history).

Understanding Normal HRV Ranges and What Shifts Them

"Normal" HRV depends on age, sex, fitness level, and recording method. A 25-year-old endurance athlete might have an overnight RMSSD of 80 ms. A sedentary 60-year-old might sit at 18 ms without any identifiable pathology.

General population benchmarks from a large Finnish cohort study (N=10,957) using 5-minute supine recordings placed median RMSSD at 27.1 ms for men aged 40-49 and 24.3 ms for women in the same age bracket [12]. SDNN medians were 35-50 ms across age groups. Values below the 10th percentile for age and sex warrant clinical attention.

HRV declines approximately 1-2 ms per decade of adult life. Acute shifts matter more than absolute values. A sudden 30% drop in a person's own baseline, sustained over two or more weeks, is more clinically meaningful than comparing to population norms.

Factors that acutely suppress HRV include alcohol consumption (even moderate intake reduces overnight RMSSD by 15-22% per a 2018 study in JMIR Mental Health), sleep deprivation (one night of restricted sleep drops RMSSD by roughly 10-15%), acute illness, and dehydration [13]. Any lab interpretation should account for these confounders.

How to Raise Low HRV: Evidence-Based Interventions

Interventions that reliably improve HRV target the underlying cause identified by the paired lab panel.

Aerobic exercise. A Cochrane review of 19 RCTs found that moderate-intensity aerobic exercise (150 minutes per week, sustained for 12 or more weeks) increased RMSSD by a weighted mean of 3.1 ms in previously sedentary adults [14]. The effect was larger in those with baseline metabolic abnormalities.

Slow-paced breathing (resonance frequency breathing). Breathing at approximately 5.5-6 breaths per minute for 10-20 minutes daily has the strongest short-term evidence. A randomized trial (N=46) published in Applied Psychophysiology and Biofeedback demonstrated a sustained increase in resting RMSSD of 4.8 ms after 4 weeks of daily practice [15].

Correcting thyroid dysfunction. When TSH is elevated and free T4 is low-normal or low, starting levothyroxine addresses one of the most correctable causes of reduced HRV. The improvement timeline is 3-6 months.

Insulin sensitization. Metformin and lifestyle modification both improve HRV in insulin-resistant patients. The Diabetes Prevention Program (N=3,234) showed that the lifestyle intervention arm, which achieved 7% weight loss, had the greatest improvement in cardiac autonomic markers at 3.2 years of follow-up [16].

Magnesium repletion. If RBC magnesium is low, oral supplementation (magnesium glycinate or taurate, 200-400 mg elemental per day) addresses the deficit. Allow 8-12 weeks for measurable HRV changes.

Sleep optimization. Fixing obstructive sleep apnea with CPAP is one of the most dramatic HRV interventions available. A study in Chest (N=38) showed that 3 months of CPAP use increased SDNN by 28% and RMSSD by 34% in moderate-to-severe OSA patients [17].

What High HRV Means (and When It Is Not a Good Sign)

High HRV generally indicates strong parasympathetic tone and is associated with cardiovascular fitness, youth, and good recovery capacity. Athletes routinely record RMSSD values above 60-80 ms. This is not a concern.

There are exceptions. Excessively high HRV with prominent low-frequency oscillations can signal pathological autonomic instability. Specific conditions include third-degree AV block, vasovagal syncope disorders, and certain channelopathies. These are rare. If a patient reports recurrent syncope or near-syncope alongside unusually high HRV readings, a cardiology referral with Holter monitoring is appropriate rather than additional lab work.

In the general population, high HRV paired with good subjective well-being requires no workup. The lab panel described above is indicated for low or declining HRV, not high readings.

Medications That Alter HRV Readings

Interpretation of HRV always requires a medication review. Several drug classes directly change autonomic tone.

Beta-blockers increase HRV by reducing sympathetic input. A patient on metoprolol may show "improved" HRV that reflects pharmacology, not true autonomic health. Anticholinergic medications (diphenhydramine, oxybutynin, tricyclic antidepressants) suppress parasympathetic tone and lower HRV. SSRIs have variable effects; some data suggest citalopram may mildly increase HRV, while paroxetine may reduce it due to anticholinergic properties [18].

GLP-1 receptor agonists (semaglutide, tirzepatide) have shown neutral to mildly positive effects on HRV in post-hoc analyses of cardiovascular outcome trials, likely mediated through weight loss and improved insulin sensitivity rather than direct autonomic effects [19].

Document current medications before interpreting any HRV-lab correlation. A change in medication is not the same as a change in autonomic function.

Recording Quality: Wearable vs. Clinical-Grade HRV

Consumer wearables (Apple Watch, Oura Ring, Whoop, Garmin) measure HRV using photoplethysmography (PPG) at the wrist or finger. PPG-derived HRV correlates reasonably well with ECG-derived values during sleep (r = 0.85-0.92 in validation studies), but accuracy drops during movement and in individuals with darker skin tones or peripheral vascular disease [20].

For clinical decision-making, confirm wearable trends with a 5-minute supine ECG recording. This can be done with a clinical-grade portable ECG device (Polar H10, Movesense, or a standard 12-lead). The Task Force of the European Society of Cardiology recommends a minimum 5-minute recording under standardized conditions for short-term analysis and 24 hours for frequency-domain metrics [2].

Do not order a $300 lab panel based solely on one low HRV reading from a consumer device after a night of poor sleep. Establish a trend over at least 7-14 days, ideally with morning or overnight recordings, before pursuing bloodwork.

Putting It All Together: A Decision Framework

The ordering logic follows a simple branch. If HRV is consistently low (below the 10th percentile for age/sex or a sustained 30%+ decline from personal baseline over two or more weeks), start with the core seven-test panel: HbA1c, fasting insulin, fasting glucose, hsCRP, TSH with free T4, morning cortisol, and a lipid panel.

If the core panel is unremarkable and HRV remains low, add DHEA-S, total and free testosterone (in men or symptomatic women), RBC magnesium, ferritin, and a sleep study referral if symptoms suggest OSA. Consider a 24-hour Holter monitor if cardiac arrhythmia is suspected.

If the core panel reveals a specific abnormality (elevated TSH, elevated A1c, elevated hsCRP), treat that condition and re-check HRV at 8-12 weeks. HRV monitoring becomes a tracking biomarker for treatment response, not a diagnostic endpoint.

Dr. Robert Lustig, Professor Emeritus of Pediatrics at UCSF, has noted: "HRV is the check-engine light. The lab panel is what tells you whether the problem is the spark plugs or the transmission."

The American College of Cardiology's 2023 consensus on wearable-derived biometrics recommended that "clinicians integrate consumer-derived HRV data with established clinical biomarkers rather than acting on HRV values in isolation" [21].

Recheck HRV and the relevant abnormal labs together at 8-12 week intervals to assess treatment response. Clinically meaningful improvement is a sustained RMSSD increase of 5 ms or more from the treated baseline.